Technology
Global smartphone market hits 380mn units in Q3
New Delhi, Oct 31
Showing a sign of recovery, the global smartphone market saw 380 million units in shipments, as compared to 379.8 million units in Q3 2018, Counterpoint Research said on Thursday.
Samsung led the market with 21 per cent share with strong demand for its A and Note smartphone series while Huawei reached a record high with 18 per cent share.
Realme was the fastest growing brand, reaching the 7th spot globally.
"The global smartphone market ended a long period of continuous YoY declines in Q3 2019 due to increased shipments in India and China," said Shobhit Srivastava, Research Analyst at Counterpoint Research.
The top three brands, Samsung, Huawei and Apple, together cornered almost half of the smartphone market, with the rest of the market left for hundreds of other brands to compete fiercely.
Apple iPhone shipments were down 4 per cent, and as a result, revenues fell 11 per cent YoY.
The positive response for the latest iPhone 11 series during the tail end of the quarter is a silver lining for Apple going into the holiday season quarter, said the report.
Tarun Pathak, Associate Director at Counterpoint Research, said that the US trade ban on Huawei did not affect the overall brand's shipments and growth in Q3 2019 after the uncertainties in June.
"Huawei's strategy to supplement its decline in overseas market share with domestic push paid off handsomely.
"The rising sense of nationalism towards Huawei amidst US-China trade war coupled with aggressive go-to-market strategy in China helped Huawei boost mindshare and marketshare domestically," Pathak noted.
Samsung led the market with 21 per cent share with strong demand for its A and Note smartphone series while Huawei reached a record high with 18 per cent share.
Realme was the fastest growing brand, reaching the 7th spot globally.
"The global smartphone market ended a long period of continuous YoY declines in Q3 2019 due to increased shipments in India and China," said Shobhit Srivastava, Research Analyst at Counterpoint Research.
The top three brands, Samsung, Huawei and Apple, together cornered almost half of the smartphone market, with the rest of the market left for hundreds of other brands to compete fiercely.
Apple iPhone shipments were down 4 per cent, and as a result, revenues fell 11 per cent YoY.
The positive response for the latest iPhone 11 series during the tail end of the quarter is a silver lining for Apple going into the holiday season quarter, said the report.
Tarun Pathak, Associate Director at Counterpoint Research, said that the US trade ban on Huawei did not affect the overall brand's shipments and growth in Q3 2019 after the uncertainties in June.
"Huawei's strategy to supplement its decline in overseas market share with domestic push paid off handsomely.
"The rising sense of nationalism towards Huawei amidst US-China trade war coupled with aggressive go-to-market strategy in China helped Huawei boost mindshare and marketshare domestically," Pathak noted.
1 hour ago
Los Angeles wildfires: Death toll rises to 24
2 hours ago
Saraswathi returned to the crumbling house, carrying the lifeless body of her son.
3 hours ago
The petrol pumps in the state will remain closed today from 6 AM to 12 noon.
4 hours ago
Israeli PM Netanyahu, US Prez Biden discuss Gaza hostage deal
4 hours ago
Two Myanmar nationals held in Mizoram with huge haul of foreign currency
4 hours ago
50 lakh people take dip in Sangam a day ahead of Paush Purnima
4 hours ago
Collective efforts needed to inculcate sense of oneness: Manipur CM
4 hours ago
There is no water; firefighters are struggling to control the wildfire.
4 hours ago
J&K L-G, CM Omar extend warm wishes on Lohri, Makar Sankranti, emphasises togetherness, prosperity
4 hours ago
Youth must transform ideas into reality for a Viksit Bharat: Jitendra Singh
4 hours ago
Steve Jobs' wife Laurene Powell prays at UP temple, to visit Maha Kumbh
4 hours ago
After 7.93 pc reduction in GHG emissions, India committed to sustainable future: Centre
4 hours ago
Once monthly injectables to become future therapeutic options for obesity: Report